Investing Profile

Jonathan Silverstein

VC

Photo of Jonathan Silverstein, OrbiMed Advisors

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
OrbiMed Advisors
23
CompanyStageDateRound SizeTotal Raised
Prevail Therapeutics
Series AMar 2018$75M
$75M
resTORbio
Series BNov 2017$40M
$40M
NeuroPace
Venture RoundOct 2017$74M
$74M
Audentes Therapeutics
Series COct 2015$65M
Series BDec 2014$42.5M
$107.5M
Glaukos
Series FFeb 2013$30M
Series EFeb 2011$29.5M
Series DAug 2008$35M
$94.5M
Co-investors: Paul Madera (Meritech Capital Partners), Gil Kliman (InterWest)
Relypsa
Venture RoundOct 2012$2.6M
Series CAug 2012$80M
Private Equity RoundJul 2012$62.4M
Series BAug 2011$70.1M
Series BSep 2010$70M
$285.1M
Roka Bioscience
Series DJan 2012$47.5M
Series CJul 2011$20M
$67.5M
Co-investors: Josh Bilenker (Aisling Capital), James Barrett
SuperDimension
Debt FinancingSep 2010$15M
Series BJun 2005$27M
$42M
Co-Founder The Silverstein Foundation for Parkinson's with GBA2017 - Present
Co-Head of Private Equity and General Partner OrbiMed Advisors1999 - Present
University of San Diego Doctor of Law (JD) and MBA
Denison University Bachelor's degree Economics